CellOrigin Biotech
About:
CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.
Website: http://en.cell-origin.com/
Top Investors: LYFE Capital, Yinxinggu Capital, Goldport Capital, KUNLUN, Kunlun Capital
Description:
CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.
Total Funding Amount:
100M CNY
Headquarters Location:
Hangzhou, Zhejiang, China
Founded Date:
2018-01-01
Contact Email:
info(AT)cell-origin.com
Founders:
Jin Zhang
Number of Employees:
101-250
Last Funding Date:
2023-09-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai